Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mark Cuban-backed Genetesis granted second key FDA 'breakthrough' designation By: Cincinnati Business Courier via Business Journals April 13, 2023 at 13:22 PM EDT Genetesis, a Mason medtech startup backed by Mark Cuban and others, has landed its second key clearance from the U.S. Food and Drug Administration — its next step in pursuing full market authorization as part of its goal to better treat millions of cardiac patients. Read More >> Related Stocks: Harbor Disruptive Innovation ETF Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Mark Cuban-backed Genetesis granted second key FDA 'breakthrough' designation By: Cincinnati Business Courier via Business Journals April 13, 2023 at 13:22 PM EDT Genetesis, a Mason medtech startup backed by Mark Cuban and others, has landed its second key clearance from the U.S. Food and Drug Administration — its next step in pursuing full market authorization as part of its goal to better treat millions of cardiac patients. Read More >> Related Stocks: Harbor Disruptive Innovation ETF